Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency

Open access

Abstract

Genetic models of ribosome dysfunction show selective organ failure, highlighting a gap in our understanding of cell-type specific responses to translation insufficiency. Translation defects underlie a growing list of inherited and acquired cancer-predisposition syndromes referred to as ribosomopathies. We sought to identify molecular mechanisms underlying organ failure in a recessive ribosomopathy, with particular emphasis on the pancreas, an organ with a high and reiterative requirement for protein synthesis. Biallelic loss of function mutations in SBDS are associated with the ribosomopathy Shwachman-Diamond syndrome, which is typified by pancreatic dysfunction, bone marrow failure, skeletal abnormalities and neurological phenotypes. Targeted disruption of Sbds in the murine pancreas resulted in p53 stabilization early in the postnatal period, specifically in acinar cells. Decreased Myc expression was observed and atrophy of the adult SDS pancreas could be explained by the senescence of acinar cells, characterized by induction of Tgfβ, p15(Ink4b) and components of the senescence-associated secretory program. This is the first report of senescence, a tumour suppression mechanism, in association with SDS or in response to a ribosomopathy. Genetic ablation of p53 largely resolved digestive enzyme synthesis and acinar compartment hypoplasia, but resulted in decreased cell size, a hallmark of decreased translation capacity. Moreover, p53 ablation resulted in expression of acinar dedifferentiation markers and extensive apoptosis. Our findings indicate a protective role for p53 and senescence in response to Sbds ablation in the pancreas. In contrast to the pancreas, the Tgfβ molecular signature was not detected in fetal bone marrow, liver or brain of mouse models with constitutive Sbds ablation. Nevertheless, as observed with the adult pancreas phenotype, disease phenotypes of embryonic tissues, including marked neuronal cell death due to apoptosis, were determined to be p53-dependent. Our findings therefore point to cell/tissue-specific responses to p53-activation that include distinction between apoptosis and senescence pathways, in the context of translation disruption.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1005288

Cites

Statistics

Figures

Fig 1 Sbds mutants display ribosomopathy and SDS phenotypes. A, Embryos with biallelic mutations in Sbds have decreased mass compared with littermate controls, **P<4X10-6. Sbds R126T/–embryos are smaller than Sbds R126T/R126T embryos, *P = 1.9X10-4 (Wilcoxon Rank Sum Test; Kruskal-Wallis P = 3.0X10-8). Error bars represent ±SEM. Scale bar represents 5 mm (upper panel). B, Decreased granulocytes (dark purple, H&E, E18.5) in liver (cell cluster examples are indicated with yellow arrowheads) and bone marrow (black arrowheads) with loss of Sbds; N = 3 (Sbds R126T/R126T) and 4 (Sbds R126T/–). Scale bars represent 100 μm. C, Decreased bone ossification was observed in transverse metacarpal sections of mutants (corresponding regions of littermate controls that maintain red Safranin O staining in mutants are highlighted with magenta arrowheads, E18.5). Scale bars represent 100 μm.
Fig 1 Sbds mutants display ribosomopathy and SDS phenotypes. A, Embryos with biallelic mutations in Sbds have decreased mass compared with littermate controls, **P<4X10-6. Sbds R126T/–embryos are smaller than Sbds R126T/R126T embryos, *P = 1.9X10-4 (Wilcoxon Rank Sum Test; Kruskal-Wallis P = 3.0X10-8). Error bars represent ±SEM. Scale bar represents 5 mm (upper panel). B, Decreased granulocytes (dark purple, H&E, E18.5) in liver (cell cluster examples are indicated with yellow arrowheads) and bone marrow (black arrowheads) with loss of Sbds; N = 3 (Sbds R126T/R126T) and 4 (Sbds R126T/–). Scale bars represent 100 μm. C, Decreased bone ossification was observed in transverse metacarpal sections of mutants (corresponding regions of littermate controls that maintain red Safranin O staining in mutants are highlighted with magenta arrowheads, E18.5). Scale bars represent 100 μm.CC BY · PubMed Central
Fig 2 SDS brain is apoptotic. Histochemistry of transverse rhombencephalon (E11.5; A) and telencephalon (E14.5; B) brain sections indicate hypocellularity and neuronal cell death (green in TUNEL panels) in post-mitotic regions of Sbds R126T/R126T mice with earlier onset in the Sbds R126T/–mice (compare TUNEL panels in A and B). Bromodeoxyuridine labeling (brown in BrdU panels) highlighted reduced proliferation of neural progenitors. V, lateral ventricle; VZ, ventricular zone; IZ, intermediate zone; CP, cortical plate. Scale bars represent 25 μm.
Fig 2 SDS brain is apoptotic. Histochemistry of transverse rhombencephalon (E11.5; A) and telencephalon (E14.5; B) brain sections indicate hypocellularity and neuronal cell death (green in TUNEL panels) in post-mitotic regions of Sbds R126T/R126T mice with earlier onset in the Sbds R126T/–mice (compare TUNEL panels in A and B). Bromodeoxyuridine labeling (brown in BrdU panels) highlighted reduced proliferation of neural progenitors. V, lateral ventricle; VZ, ventricular zone; IZ, intermediate zone; CP, cortical plate. Scale bars represent 25 μm.CC BY · PubMed Central
Fig 3 Senescence-associated markers in the SDS pancreas. A, Senescence-associated β-galactosidase activity (SA-bgal, bright blue) was detected in acini of the SDS pancreas at 30 days of age (N = 5). Sbds P–/+ and Sbds P–/R126T are shorthand for Sbds CKO/+; Ptf1a Cre/+ and Sbds CKO/R126T; Ptf1a Cre/+, respectively [51]. Scale bars represent 100 μm. B, 84 cellular-senescence associated genes were assayed using the SABiosciences Cellular Senescence RT2 Profiler PCR Array (QIAGEN) with total RNA isolated from pancreata of mice at 15 and 25 days of age. Table lists transcripts that showed statistically significant changes relative to control genes at at least one of the two assayed time points (see also S2 Table). Fold change: Sbds P-/R126T/Sbds P-/+. Criteria for significance (as per supplier’s instructions): ≥3 fold difference with a P-value of <0.05, N = 3 at each time point. C and D, Quantitative transcript analysis. In C, fold change: Sbds P-/R126T/Sbds P-/+; N = 4 at each time point, except at E18.5 where N = 3. Criteria for significance: ≥2 fold change, P<0.05. E18.5 pancreas expression is relative to Tbp; P8-P25 expression is relative to Gapdh. In D, fold change: Sbds R126T/R126T/Sbds R126T/+; N = 4. Criteria for significance: ≥2 fold change, P<0.05. Brain and liver expression is relative to Actb; bone expression is relative to Tbp. All P-values calculated using unpaired, two-tailed T-tests. Red indicates down-regulation, blue indicates up-regulation. Abbreviations in B: Akt1: Thymoma viral proto-oncogene 1; Cd44: CD44 antigen; Cdkn1a: Cyclin-dependent kinase inhibitor 1A; Ckdn2b: Cyclin-dependent kinase inhibitor 2B; Col1a1: Collagen, type I, alpha 1; Creg1: Cellular repressor of E1A-stimulated genes 1; Egr1: Early growth response 1; Ets1: E26 avian leukemia oncogene 1, 5’ domain; Fn1: Fibronectin 1; Hras1: Harvey rat sarcoma virus oncogene 1; Ifng: Interferon gamma; Igfbp5: Insulin-like growth factor binding protein 5; Igfbp7: Insulin-like growth factor binding protein 7; Interferon regulatory factor 3; Irf5: Interferon regulatory factor 5; Irf7: Interferon regulatory factor 7; Myc: Myelocytomatosis oncogene; Nfkb1: Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105; Sparc: Secreted acidic cysteine rich glycoprotein (osteonectin; Tbx3: T-box-3; Tgfb1: Transforming growth factor, beta 1; Tgfb1i1: Transforming growth factor beta 1 induced transcript 1.
Fig 3 Senescence-associated markers in the SDS pancreas. A, Senescence-associated β-galactosidase activity (SA-bgal, bright blue) was detected in acini of the SDS pancreas at 30 days of age (N = 5). Sbds P–/+ and Sbds P–/R126T are shorthand for Sbds CKO/+; Ptf1a Cre/+ and Sbds CKO/R126T; Ptf1a Cre/+, respectively [51]. Scale bars represent 100 μm. B, 84 cellular-senescence associated genes were assayed using the SABiosciences Cellular Senescence RT2 Profiler PCR Array (QIAGEN) with total RNA isolated from pancreata of mice at 15 and 25 days of age. Table lists transcripts that showed statistically significant changes relative to control genes at at least one of the two assayed time points (see also S2 Table). Fold change: Sbds P-/R126T/Sbds P-/+. Criteria for significance (as per supplier’s instructions): ≥3 fold difference with a P-value of <0.05, N = 3 at each time point. C and D, Quantitative transcript analysis. In C, fold change: Sbds P-/R126T/Sbds P-/+; N = 4 at each time point, except at E18.5 where N = 3. Criteria for significance: ≥2 fold change, P<0.05. E18.5 pancreas expression is relative to Tbp; P8-P25 expression is relative to Gapdh. In D, fold change: Sbds R126T/R126T/Sbds R126T/+; N = 4. Criteria for significance: ≥2 fold change, P<0.05. Brain and liver expression is relative to Actb; bone expression is relative to Tbp. All P-values calculated using unpaired, two-tailed T-tests. Red indicates down-regulation, blue indicates up-regulation. Abbreviations in B: Akt1: Thymoma viral proto-oncogene 1; Cd44: CD44 antigen; Cdkn1a: Cyclin-dependent kinase inhibitor 1A; Ckdn2b: Cyclin-dependent kinase inhibitor 2B; Col1a1: Collagen, type I, alpha 1; Creg1: Cellular repressor of E1A-stimulated genes 1; Egr1: Early growth response 1; Ets1: E26 avian leukemia oncogene 1, 5’ domain; Fn1: Fibronectin 1; Hras1: Harvey rat sarcoma virus oncogene 1; Ifng: Interferon gamma; Igfbp5: Insulin-like growth factor binding protein 5; Igfbp7: Insulin-like growth factor binding protein 7; Interferon regulatory factor 3; Irf5: Interferon regulatory factor 5; Irf7: Interferon regulatory factor 7; Myc: Myelocytomatosis oncogene; Nfkb1: Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105; Sparc: Secreted acidic cysteine rich glycoprotein (osteonectin; Tbx3: T-box-3; Tgfb1: Transforming growth factor, beta 1; Tgfb1i1: Transforming growth factor beta 1 induced transcript 1.CC BY · PubMed Central
Fig 4 Tgfβ and p53 response in the SDS pancreas. A, Steady state protein levels paralleled observed transcript changes with decreased Myc and increased p21Cip and Tgfβ expression, along with changes in Smad2 and Smad3 phosphorylation status in mutants. Representative immunoblots of lysates from four littermate pairs at 3 weeks of age are shown. Associated densitometry is shown in right graphs, with Myc, Tgfβ, and p21 relative to Gapdh expression, and phosphorylated-Smad2 and Smad3 relative to total Smad2 and Smad3, respectively. Horizontal lines in scatter plots indicate mean values. B, Representative immunoblot indicates stabilization of p53 protein in the SDS pancreas at 3 weeks of age with associated densitometry (expression relative to calnexin) below. Horizontal lines indicate mean values. C, Immunohistochemistry indicated p53 stabilization as early as 15 days of age (sections shown are of littermates). Yellow arrows highlight examples of positive nuclei. p53 staining was observed specifically in nuclei of acinar cells of the SDS pancreas model (islets denoted with pale yellow dashed outlines). Scale bars represent 50 μm.
Fig 4 Tgfβ and p53 response in the SDS pancreas. A, Steady state protein levels paralleled observed transcript changes with decreased Myc and increased p21Cip and Tgfβ expression, along with changes in Smad2 and Smad3 phosphorylation status in mutants. Representative immunoblots of lysates from four littermate pairs at 3 weeks of age are shown. Associated densitometry is shown in right graphs, with Myc, Tgfβ, and p21 relative to Gapdh expression, and phosphorylated-Smad2 and Smad3 relative to total Smad2 and Smad3, respectively. Horizontal lines in scatter plots indicate mean values. B, Representative immunoblot indicates stabilization of p53 protein in the SDS pancreas at 3 weeks of age with associated densitometry (expression relative to calnexin) below. Horizontal lines indicate mean values. C, Immunohistochemistry indicated p53 stabilization as early as 15 days of age (sections shown are of littermates). Yellow arrows highlight examples of positive nuclei. p53 staining was observed specifically in nuclei of acinar cells of the SDS pancreas model (islets denoted with pale yellow dashed outlines). Scale bars represent 50 μm.CC BY · PubMed Central
Fig 5 Atrophic SDS pancreas phenotype is p53-dependent. A, Improved mass of SDS pancreas with loss of p53 (Sbds P–/R126T; Trp53 –/–; 30 days of age); *P = 0.0025, **P<4X10-5, Wilcoxon Rank Sum Test (Kruskal-Wallis Test P = 3.2X10-5). Inset numbers = N. Error bars represent ±SEM. B, Resolution of atrophy and hypocellularity as well as fat infiltration with loss of p53 in SDS pancreas at 60 days of age (H&E). However, multiple apoptotic acinar cells (TUNEL) per field of view and increased expression of dedifferentiation markers in acini (examples of Hes1 and Pdx1 positive cells, yellow arrowheads) highlighted dysplasia. I: islets. Scale bar represents 100 μm. C, Improvement in digestive enzyme expression and abrogation of senescence-related changes in Tgfβ/p15Ink4b and Myc expression in double mutants at 25 days of age. Fold changes correspond to the comparison of Sbds P–/R126T;Trp5 +/–to Sbds P–/+;Trp53 +/–or Sbds P–/R126T;Trp53 –/–to Sbds P–/+;Trp53 –/–transcript levels. P-values calculated using unpaired, two-sided T-tests.
Fig 5 Atrophic SDS pancreas phenotype is p53-dependent. A, Improved mass of SDS pancreas with loss of p53 (Sbds P–/R126T; Trp53 –/–; 30 days of age); *P = 0.0025, **P<4X10-5, Wilcoxon Rank Sum Test (Kruskal-Wallis Test P = 3.2X10-5). Inset numbers = N. Error bars represent ±SEM. B, Resolution of atrophy and hypocellularity as well as fat infiltration with loss of p53 in SDS pancreas at 60 days of age (H&E). However, multiple apoptotic acinar cells (TUNEL) per field of view and increased expression of dedifferentiation markers in acini (examples of Hes1 and Pdx1 positive cells, yellow arrowheads) highlighted dysplasia. I: islets. Scale bar represents 100 μm. C, Improvement in digestive enzyme expression and abrogation of senescence-related changes in Tgfβ/p15Ink4b and Myc expression in double mutants at 25 days of age. Fold changes correspond to the comparison of Sbds P–/R126T;Trp5 +/–to Sbds P–/+;Trp53 +/–or Sbds P–/R126T;Trp53 –/–to Sbds P–/+;Trp53 –/–transcript levels. P-values calculated using unpaired, two-sided T-tests.CC BY · PubMed Central
Fig 6 SDS pancreas senescence is downstream of p53-dependent changes in protein synthesis. A, Increased nuclei per acinar area (*P = 0.029, Wilcoxon Rank Sum Test) and B, decreased mean acinus diameter (**P = 0.0073 and NS = not significant, P = 0.142; unpaired, two-sided T-test) in Sbds P–/R126T; Trp53 –/–pancreas at 30 days of age. Error bars represent ±SEM; in boxplots, whiskers represent extreme values; circles, outliers. C, Coomassie and silver staining of pancreas lysate SDS-PAGE illustrated p53-dependent altered protein expression in the SDS pancreas (20 days of age, 6 μg total protein loaded). D, Immunoblotting confirmed that digestive enzymes were reduced in expression in the SDS pancreas, with expression of protease carboxypeptidase (Cpa1) increasing in a Trp53 –/–genetic background (3 weeks of age, 25 μg total protein loaded). Representative blots are shown. Associated densitometry, with expression relative to Gapdh, is shown in lower panels, Sbds P–/+ black, Sbds P–/R126T grey, horizontal lines indicate mean values. E, Restoration of zymogen granules (example, white arrowhead) with loss of p53 was observed by one week of age (electron micrographs). Scale bar represents 5 μm. F, Representative polysome traces illustrate restoration of 80S peak in mutants to levels similar to those of controls with loss of p53 (20 days of age, 79 μg RNA loaded, N = 4 (Trp53 +/–) and 3(Trp53 –/–)). P: polysomes.
Fig 6 SDS pancreas senescence is downstream of p53-dependent changes in protein synthesis. A, Increased nuclei per acinar area (*P = 0.029, Wilcoxon Rank Sum Test) and B, decreased mean acinus diameter (**P = 0.0073 and NS = not significant, P = 0.142; unpaired, two-sided T-test) in Sbds P–/R126T; Trp53 –/–pancreas at 30 days of age. Error bars represent ±SEM; in boxplots, whiskers represent extreme values; circles, outliers. C, Coomassie and silver staining of pancreas lysate SDS-PAGE illustrated p53-dependent altered protein expression in the SDS pancreas (20 days of age, 6 μg total protein loaded). D, Immunoblotting confirmed that digestive enzymes were reduced in expression in the SDS pancreas, with expression of protease carboxypeptidase (Cpa1) increasing in a Trp53 –/–genetic background (3 weeks of age, 25 μg total protein loaded). Representative blots are shown. Associated densitometry, with expression relative to Gapdh, is shown in lower panels, Sbds P–/+ black, Sbds P–/R126T grey, horizontal lines indicate mean values. E, Restoration of zymogen granules (example, white arrowhead) with loss of p53 was observed by one week of age (electron micrographs). Scale bar represents 5 μm. F, Representative polysome traces illustrate restoration of 80S peak in mutants to levels similar to those of controls with loss of p53 (20 days of age, 79 μg RNA loaded, N = 4 (Trp53 +/–) and 3(Trp53 –/–)). P: polysomes.CC BY · PubMed Central
Fig 7 Hematopoietic and neuronal SDS phenotypes are p53-dependent. A, Restored hematopoietic progenitor colony forming units in constitutive SDS model with loss of p53 (E16.5 fetal liver; N = 5). CFU, colony forming unit; GEMM, granulocyte/erythroid/macrophage/ megakaryocyte; GM, granulocyte/macrophage; M, macrophage; G, granulocyte; BFU-E, burst forming unit-erythroid. P-values calculated using Wilcoxon Rank Sum Test comparing SDS models with (Trp53 +/–) and without p53 (Trp53 –/–). Horizontal lines indicate mean values. See S3 Table for complete statistics. B, Restored morphology and cell viability in the SDS mouse brain with loss of p53 (E14.5; VZ: ventricular zone). Scale bars for H&E sections represent 1000 μm (left panels) and 100 μm (right panels). Scale bars for TUNEL sections represent 50 μm. Yellow arrowheads highlight the zone of pronounced staining. C, Representative polysome traces illustrate that 80S peak levels remained low in mutant livers regardless of p53 status (E18.5, 100 μg RNA loaded).
Fig 7 Hematopoietic and neuronal SDS phenotypes are p53-dependent. A, Restored hematopoietic progenitor colony forming units in constitutive SDS model with loss of p53 (E16.5 fetal liver; N = 5). CFU, colony forming unit; GEMM, granulocyte/erythroid/macrophage/ megakaryocyte; GM, granulocyte/macrophage; M, macrophage; G, granulocyte; BFU-E, burst forming unit-erythroid. P-values calculated using Wilcoxon Rank Sum Test comparing SDS models with (Trp53 +/–) and without p53 (Trp53 –/–). Horizontal lines indicate mean values. See S3 Table for complete statistics. B, Restored morphology and cell viability in the SDS mouse brain with loss of p53 (E14.5; VZ: ventricular zone). Scale bars for H&E sections represent 1000 μm (left panels) and 100 μm (right panels). Scale bars for TUNEL sections represent 50 μm. Yellow arrowheads highlight the zone of pronounced staining. C, Representative polysome traces illustrate that 80S peak levels remained low in mutant livers regardless of p53 status (E18.5, 100 μg RNA loaded).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 92 · Cited by 47

Metadata

Authors
Tourlakis, M. E., Zhang, S., Ball, H. L., Gandhi, R., Liu, H., Zhong, J., Yuan, J. S., Guidos, C. J., Durie, P. R., & Rommens, J. M.
Affiliations
  • University of Toronto (CA)
  • Hospital for Sick Children (CA)
Corresponding author
Rommens, Johanna M.
Venue
PLOS Genetics
Published
2015-06-09
Volume
11
Issue
6
Pages
e1005288
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W625857439
Cited by
47
References
92
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 5
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Toronto
  • Hospital for Sick Children
  • Canadian Institutes of Health Research (FRN11530, MOP102506)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Hematology › Blood disorders and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
Shwachman-Diamond syndrome, SBDS, ribosomopathies, cellular senescence, p53, pancreatic acinar cells, TGF-beta, senescence-associated secretory phenotype, c-Myc, apoptosis, organ failure, cell type-specific responses
MeSH terms
Shwachman-Diamond Syndrome, Animals, Bone Marrow Diseases, Cells, Cultured, Lipomatosis, Mice, Inbred C57BL, Pancreas, Exocrine Pancreatic Insufficiency, Proteins, Ribosomes, Protein Biosynthesis, Tumor Suppressor Protein p53, Transforming Growth Factor beta, Cellular Senescence, Apoptosis, Mice, Acinar Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency. https://app.cochat.ai/papers/10.1371/journal.pgen.1005288
The paper
Tourlakis, M. E., Zhang, S., Ball, H. L., Gandhi, R., Liu, H., Zhong, J., Yuan, J. S., Guidos, C. J., Durie, P. R., & Rommens, J. M. (2015). In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1005288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.